August 4, 2021

XACT pic hand400x275XACT Robotics has announced that the company’s robotic system has been used in more than 100 percutaneous procedures in the human body. The system is a “hands-free” robotic system that aims to improve targeting accuracy, efficiency, and consistency in percutaneous procedures, enabling doctors to reach small targets inside the body, potentially supporting earlier diagnosis and intervention.

The company said in more than 100 cases performed at leading medical centers in the U.S. and Israel, including Lahey Hospital & Medical Center, Sarasota Interventional Radiology and Hadassah Medical Center, the XACT robotic system was consistently able to reach small areas of interest in the abdomen and lung.

“We are very pleased to be commemorating this historic milestone, which is a reflection of the dedication of our employees and the radiology teams who have recognized the considerable advantages that this technology delivers to patients and hospital systems,” said Chen Levin, CEO of XACT Robotics. “This significant achievement is especially impressive given that we launched the system and reached over 100 cases even during the COVID-19 pandemic. As more hospitals around the world adopt XACT’s robotic system and access to care continues to expand, we anticipate achieving new levels of momentum in the adoption of this technology by leading radiology practices around the world.”

The system combines image-based procedure planning and monitoring with hands-free robotic insertion and steering capabilities to deliver instruments to a desired target in the body. XACT said it is the only technology that can steer an instrument through a non-linear trajectory.

In percutaneous procedures for diagnosing and treating certain cancers and other diseases, accuracy in reaching targets of interest within the body is extremely important, the company said. In many cases, movement caused by the patient or within the body can change the location of the target of interest during the procedure. With manual percutaneous procedures, it is often necessary to repeat a procedure if an instrument does not reach its target successfully, increasing risk for patients and healthcare providers. XACT said its technology helps improve accuracy and consistency, letting users reach targets that are small or in hard-to-reach areas, typically on the first insertion, which can lead to better patient outcomes.

“Since adopting this system, we have been impressed by the robot’s ability to consistently reach very small targets on the first insertion regardless of tissue density, structure, or elements,” said Dr. Gerald Grubbs, radiologist at Sarasota Interventional Radiology. “The robot can also reach the target even if it moves. THe accuracy of the XACT ACE Robotic System has helped us reach locations in the body that would be very challenging using traditional manual methods, and it represents a significant advance in care for patients with cancer and other serious diseases.”

Founded in 2013, XACT Robotics includes offices in Hingham, Mass., and Caesarea, Israel. For more details on the company and its robotics system, visit its website here.